Changchun To Build Northeast China's Largest Vaccine R&D Base
This article was originally published in PharmAsia News
Executive Summary
Changchun city recently signed a strategic cooperation agreement with China Pharmaceutical Group, which was followed by another agreement involving the Changchun High-tech Development Area, the Changchun Institute of Biological Products, and Sinopharm Group